UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Treating the Patient with Tuberculosis
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
Establishing trauma referral pathways to provide urgent life-saving assistance for displaced populations and civilians remaining in Ar-Raqqa.
In July 2017, a WHO team comprising an external trauma care specialist and two WHO staff members visited the governorates of Ar-Raqqa and neighbouring Al-Ha...sakeh to assess the situation
more
Recommandations pour une Approche de Santé publique.
Juin 2013.
Systematic screening for active tuberculosis: an operational guide.
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
Advocacy report March 2011
303100 03/2011 E 1,000
Rapport de plaidoyer Mars 2011
303100 03/2011 E 1,000
WHO/CDS/TB/99.272
Distr.: General, Original: French
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
FOLLOW-UP TO THE 2011 POLITICAL DECLARATION ON HIV/AIDS: INTENSIFYING EFFORTS TO ELIMINATE HIV/AIDS | Reporting Period: January – December 2014